The New England journal of medicine
-
Comment Letter
Endothelial protein C activation in meningococcal sepsis.
-
Comment Letter
Endothelial protein C activation in meningococcal sepsis.
-
Comment Letter
Endothelial protein C activation in meningococcal sepsis.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Naltrexone in the treatment of alcohol dependence.
Although naltrexone, an opiate-receptor antagonist, has been approved by the Food and Drug Administration for the treatment of alcohol dependence, its efficacy is uncertain. ⋯ Our findings do not support the use of naltrexone for the treatment of men with chronic, severe alcohol dependence.